Diuretic Response to Cyclophosphamide in Tumor-Bearing Rats
Author Information
Author(s): Y Mizushima, K Sassa, T Hamazaki, T Fujishita, R Oosaki, M Kobayashi
Primary Institution: Toyama Medical and Pharmaceutical University
Hypothesis
How do the toxic side-effects of anti-cancer drugs change in hosts bearing MMP-9-producing tumors?
Conclusion
The nephrotoxicity from anti-cancer drugs may be altered in patients with MMP-9-producing tumors.
Supporting Evidence
- Normal rats showed oliguria after cyclophosphamide treatment, while tumor-bearing rats showed polyuria.
- Urinary NAG excretion was significantly higher in tumor-bearing rats compared to normal rats.
- No significant changes in blood urea nitrogen or serum creatinine were observed in either group after treatment.
Takeaway
When rats with a certain type of tumor were given a cancer drug, they produced more urine than normal rats, which suggests the drug affects them differently.
Methodology
Male F-344 rats were treated with cyclophosphamide and cisplatin, and urine was collected to measure volume and NAG excretion.
Limitations
The study was conducted on rats, which may not fully represent human responses.
Participant Demographics
Male F-344 rats, aged 12-14 weeks.
Statistical Information
P-Value
p<0.001 for normal rats, p<0.01 for tumor-bearing rats
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website